PTEN and breast carcinoma: To further explore the association of PTEN- with triple-negative disease and brain metastases, we interrogated two publicly available gene-expression microarray data sets that included: (a) 855 primary breast cancers with annotated intrinsic subtype and relapse-free survival data [19], and (b) 36 unpaired brain, lung, liver, and bone BC metastases [20].